These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 28029744

  • 1. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
    Blachère NE, Parveen S, Frank MO, Dill BD, Molina H, Orange DE.
    Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
    [Abstract] [Full Text] [Related]

  • 2. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D, Bawadekar M, Senolt L, Stensballe A, Shelef MA, Nielsen CH.
    PLoS One; 2018 May; 13(8):e0203214. PubMed ID: 30161253
    [Abstract] [Full Text] [Related]

  • 3. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
    Darrah E, Davis RL, Curran AM, Naik P, Chen R, Na CH, Giles JT, Andrade F.
    Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
    [Abstract] [Full Text] [Related]

  • 4. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
    Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ, Joosten LA.
    Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
    [Abstract] [Full Text] [Related]

  • 5. Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance.
    van Beers JJ, Raijmakers R, Alexander LE, Stammen-Vogelzangs J, Lokate AM, Heck AJ, Schasfoort RB, Pruijn GJ.
    Arthritis Res Ther; 2010 Sep; 12(6):R219. PubMed ID: 21182780
    [Abstract] [Full Text] [Related]

  • 6. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
    Schwenzer A, Jiang X, Mikuls TR, Payne JB, Sayles HR, Quirke AM, Kessler BM, Fischer R, Venables PJ, Lundberg K, Midwood KS.
    Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
    [Abstract] [Full Text] [Related]

  • 7. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.
    Sokolove J, Brennan MJ, Sharpe O, Lahey LJ, Kao AH, Krishnan E, Edmundowicz D, Lepus CM, Wasko MC, Robinson WH.
    Arthritis Rheum; 2013 Jul; 65(7):1719-24. PubMed ID: 23553485
    [Abstract] [Full Text] [Related]

  • 8. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.
    Damgaard D, Senolt L, Nielsen MF, Pruijn GJ, Nielsen CH.
    Arthritis Res Ther; 2014 Dec 05; 16(6):498. PubMed ID: 25475141
    [Abstract] [Full Text] [Related]

  • 9. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
    Spengler J, Lugonja B, Ytterberg AJ, Zubarev RA, Creese AJ, Pearson MJ, Grant MM, Milward M, Lundberg K, Buckley CD, Filer A, Raza K, Cooper PR, Chapple IL, Scheel-Toellner D.
    Arthritis Rheumatol; 2015 Dec 05; 67(12):3135-45. PubMed ID: 26245941
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla GE, del Toro-Arreola S, Ramírez-Dueñas MG, Ocampo-Bermudes G, Muñoz-Valle JF.
    Clin Exp Immunol; 2015 Nov 05; 182(2):119-31. PubMed ID: 26149185
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M, Shim D, Johnson CJ, Warner TF, Rebernick R, Damgaard D, Nielsen CH, Pruijn GJM, Nett JE, Shelef MA.
    J Autoimmun; 2017 Jun 05; 80():39-47. PubMed ID: 28188029
    [Abstract] [Full Text] [Related]

  • 13. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
    Poulsen TBG, Damgaard D, Jørgensen MM, Senolt L, Blackburn JM, Nielsen CH, Stensballe A.
    Sci Rep; 2021 Aug 27; 11(1):17300. PubMed ID: 34453079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
    Romero V, Darrah E, Andrade F.
    Arthritis Rheumatol; 2020 Jun 27; 72(6):912-918. PubMed ID: 31876120
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen.
    Auger I, Martin M, Balandraud N, Roudier J.
    Arthritis Rheum; 2010 Jan 27; 62(1):126-31. PubMed ID: 20039406
    [Abstract] [Full Text] [Related]

  • 19. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
    Li B, Li P, Bi L.
    Clin Rheumatol; 2020 Mar 27; 39(3):899-907. PubMed ID: 31758423
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.